Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
pulmonary_hypertension_association [2023/04/17 01:57]
liam [Corporate committee]
pulmonary_hypertension_association [2023/04/17 02:16] (current)
liam [Corporate committee]
Line 11: Line 11:
 ==== Funding ==== ==== Funding ====
  
-PHA's sponsors and donors include:((Wetherill, J. //Sponsors.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416215850/https://phassociation.org/aboutpha/sponsors/)) ((Wetherill, J. //Annual Report - 2021.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416223004/https://phassociation.org/accountability/annual-report-2021/)) ((Granato, M. J., & Brunetti, C. (2021, September 14). //PHA Annual Report 2020 by Pulmonary Hypertension Association.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416231442/https://issuu.com/phassociation/docs/pha-2020_annual_report_issuu_final)) ((Wong, B. A., & Fagan, K. A. (2020, August 6). //PHA 2019 Annual Report.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416232200/https://issuu.com/phassociation/docs/pha_2019_annual_report_-_pages))+PHA's sponsors and donors include:((Wetherill, J. //Sponsors.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416215850/https://phassociation.org/aboutpha/sponsors/)) ((Wetherill, J. //Annual Report - 2021.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416223004/https://phassociation.org/accountability/annual-report-2021/)) ((Granato, M. J., & Brunetti, C. (2021, September 14). //PHA Annual Report 2020 by Pulmonary Hypertension Association.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416231442/https://issuu.com/phassociation/docs/pha-2020_annual_report_issuu_final)) ((Wong, B. A., & Fagan, K. A. (2020, August 6). //PHA 2019 Annual Report.// Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416232200/https://issuu.com/phassociation/docs/pha_2019_annual_report_-_pages)) ((McGoon, M. D. //Annual Report 2007.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824100439/http://www.phassociation.org/document.doc?id=47))
  
 <WRAP column col4> <WRAP column col4>
Line 57: Line 57:
   * [[Northside Hospital Healthcare System]]   * [[Northside Hospital Healthcare System]]
   * [[Ontario Systems]]   * [[Ontario Systems]]
 +  * [[Oracle]]
   * [[Order Sons of Italy in America]]   * [[Order Sons of Italy in America]]
   * [[Penn Presbyterian Medical Center]]   * [[Penn Presbyterian Medical Center]]
Line 64: Line 65:
   * [[Real Estate One Charitable Foundation]]   * [[Real Estate One Charitable Foundation]]
   * [[Robert Wood Johnson Foundation]]   * [[Robert Wood Johnson Foundation]]
 +  * [[Scleroderma Foundation]]
   * [[sMiles for Katie]]   * [[sMiles for Katie]]
   * [[Springer India]]   * [[Springer India]]
Line 86: Line 88:
 [[Jim Serpico]] of [[pharmaceutical_companies:Bayer]] is chair of PHA's corporate committee. Committee member companies also provide funding to PHA, based on wording from earlier annual reports. [[Jim Serpico]] of [[pharmaceutical_companies:Bayer]] is chair of PHA's corporate committee. Committee member companies also provide funding to PHA, based on wording from earlier annual reports.
  
-Members include:((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416220234/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved July 1, 2017, from http://archive.today/2017.07.01-171109/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved August 20, 2019, from https://web.archive.org/web/20190820134625/https://phassociation.org/corporate-committee/)) ((McLaughlin, V., & Aldrighetti, R. //Annual Report 2012.// Pulmonary Hypertension Association. Retrieved November 29, 2022, from https://web.archive.org/web/20221129110205/https://phassociation.org/wp-content/uploads/2017/02/PHA-Annual-Report-2012.pdf)) ((Hicks, C. //Annual Report 2009.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46)) ((Hicks, C. //Annual Report 2009.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46))+Members include:((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416220234/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved July 1, 2017, from http://archive.today/2017.07.01-171109/https://phassociation.org/corporate-committee/)) ((//Corporate Committee.// Pulmonary Hypertension Association. Retrieved August 20, 2019, from https://web.archive.org/web/20190820134625/https://phassociation.org/corporate-committee/)) ((McLaughlin, V., & Aldrighetti, R. //Annual Report 2012.// Pulmonary Hypertension Association. Retrieved November 29, 2022, from https://web.archive.org/web/20221129110205/https://phassociation.org/wp-content/uploads/2017/02/PHA-Annual-Report-2012.pdf)) ((Hicks, C. //Annual Report 2009.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46)) ((Hicks, C. //Annual Report 2009.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46)) ((Hicks, C., & Aldrighetti, R. //Annual Report 2008.// Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824091525/http://www.phassociation.org/document.doc?id=28))
  
 <WRAP column col4> <WRAP column col4>
Line 100: Line 102:
   * [[Optum Specialty Pharmacy|BriovaRx]] (former)   * [[Optum Specialty Pharmacy|BriovaRx]] (former)
   * [[pharmaceutical_companies:Complexa]] (former)   * [[pharmaceutical_companies:Complexa]] (former)
 +  * [[pharmaceutical_companies:CoTherix]] (former)
   * [[pharmaceutical_companies:CuraScript Therapeutics]] (former)   * [[pharmaceutical_companies:CuraScript Therapeutics]] (former)
   * [[CVS Caremark]] (former)   * [[CVS Caremark]] (former)
Line 105: Line 108:
   * [[pharmaceutical_companies:Eiger BioPharmaceuticals]] (former)   * [[pharmaceutical_companies:Eiger BioPharmaceuticals]] (former)
   * [[pharmaceutical_companies:Eli Lilly]] (former)   * [[pharmaceutical_companies:Eli Lilly]] (former)
 +  * [[pharmaceutical_companies:Encysive Pharmaceuticals]] (former)
   * [[pharmaceutical_companies:Enzyvant]]   * [[pharmaceutical_companies:Enzyvant]]
   * [[pharmaceutical_companies:Gilead Sciences]] (former)   * [[pharmaceutical_companies:Gilead Sciences]] (former)
Line 115: Line 119:
   * [[medical_technology_companies:Medtronic]] (former)   * [[medical_technology_companies:Medtronic]] (former)
   * [[pharmaceutical_companies:Merck]]   * [[pharmaceutical_companies:Merck]]
 +  * [[pharmaceutical_companies:Myogen]] (former)
   * [[pharmaceutical_companies:Novartis]] (former)   * [[pharmaceutical_companies:Novartis]] (former)
   * [[pharmaceutical_companies:Pfizer]] (former)   * [[pharmaceutical_companies:Pfizer]] (former)
 +  * [[Pharmaceutical Research and Manufacturers of America]] (PhRMA - former)
   * [[pharmaceutical_companies:Reata Pharmaceuticals]] (former)   * [[pharmaceutical_companies:Reata Pharmaceuticals]] (former)
   * [[pharmaceutical_companies:Respira Therapeutics]]   * [[pharmaceutical_companies:Respira Therapeutics]]
Back to top